Doctor Profile Image

Paul M. Yonover MD FACS


Learn More
  • “Dr. Yonover has consistently given me wonderful care.. and advice. He's empathetic and very knowledgeable. I also appreciate how he will always approach my care as worrying with me rather than telling me what i need to do. He's built tremendous confidence in him. As a patient I couldn't ask for a better doctor. i trust and respect him tremendously.”

Paul M. Yonover MD FACS

Paul Yonover, M.D., is a board-certified urologist who specializes in BPH, kidney stones, prostate cancer, bladder cancer, kidney cancer, and laparoscopic surgery. After earning his bachelor's degree at Indiana University with a double major in Biology and History, he went on to Mount Sinai School of Medicine in NYC, followed by residency programs in surgery and urology at Loyola University Medical Center in Maywood, IL. Dr. Yonover has done extensive research in urology and has been published in numerous clinical journals. In addition, he is currently a Clinical Assistant Professor of Urology at the University of Illinois at Chicago College of Medicine, as well as the Chief of Urology at both Advocate Illinois Masonic Hospital and Amita Presence Saint Joseph Hospital.
Awards and Credentials
  • Castle Connolly Regional Top Doctors: 1st Edition
  • Chicago Magazine's Top Cancer Doctors in Chicago: 2017, 2019
  • Chicago Magazine's Top Doctors in Chicago: 2022, 2023, 2024
  • Centers for Medicare & Medicaid Services, Meaningful Use Stage 1 Certification: 2012
  • Physician Community Service Award, Resurrection Saint Joseph Hospital, 2007
  • Chicago Urological Society Huggins Essay Contest - Paper, First Place Award, 2003
  • Praecis Pharmaceuticals/AUA Gerald P. Murphy Scholar, 2002
  • National Institute of Health (NIH) Summer Research Fellowship, 1995
  • Alpha Lambda Delta Honor Society, 1990
  • Phi Eta Sigma Freshman Honor Society, 1990

Hospital Affiliation
Advocate Illinois Masonic Hospital - Chicago, IL
Ascension Saint Joseph Hospital - Chicago, IL

Education and Training

1999 - 2003
Loyola University Medical Center, Chicago, Illinois United States
Residency - Urology
1997 - 1999
Loyola University Medical Center, Chicago, Illinois United States
Residency - General Surgery
1997 - 1998
Loyola University Medical Center, Chicago, Illinois United States
Internship - Transitional Year
1993 - 1997
Mount Sinai School of Medicine, New York, New York United States
Doctor of Medicine
1989 - 1993
Indiana University, Bloomington, Indiana United States
Bachelor of Arts - Biology and History

Illinois State Medical License
American Board of Urology

Chicago Urological Society
Fellow of the American College of Surgeons
American Board of Urology

Special Interests
Kidney, Bladder, Prostate, and Testicular Cancer
Kidney Stones
Laser Surgery of the Urinary Tract
Laparoscopic Surgery
Da Vinci Robotic Surgery

Enzalutamide in Men with Nonmetastic, Castration-Resistant Prostate Cancer

The New England Journal of Medicine - June 28, 2018

Prostate Cancer Screening Podcast

Noted urologist makes virtual house calls for Iowans

CBS 2 Iowa

Chicago-based Urologist offers Virtual clinic to assist patients during Covid-19

News Channel 20

Chicago urologist to make virtual house calls in Northwest Indiana during COVID-19 outbreak

The Times of Northwestern Indiana

Hydrogel spacer use during prostate RT: Community experience

In this article, we discuss one particular new product and how it may herald a significant change in the landscape of radiation therapy for prostate cancer.

Metastatic Male Breast Cancer With Increased Uptake on 18F-Fluciclovine PET/CT Scan

Gill HS, Tade F, Greenwald DT, Yonover PM, Savir-Baruch B. Clin Nucl Med. 2018 Jan;43(1):23-24. doi: 10.1097/RLU.0000000000001893. PMID: 29189374

Fluorine-18-Labeled Fluciclovine PET/CT in Clinical Practice: Factors Affecting the Rate of Detection of Recurrent Prostate Cancer

Savir-Baruch B, Lovrec P, Solanki AA, Adams WH, Yonover PM, Gupta G, Schuster DM. AJR Am J Roentgenol. 2019 Oct;213(4):851-858. doi: 10.2214/AJR.19.21153. Epub 2019 Jun 19. PMID: 31216198

Role of Nephrectomy in Metastatic Kidney Cancer

Yonover PM, Sharma SK, Flanigan RC. Cancer Treat Res. 2003;116:119-35. doi: 10.1007/978-1-4615-0451-1_7. PMID: 14650829 Review. No abstract available.

The Role of Resection for Patients With Renal Carcinoma

Flanigan RC, Yonover PM. Curr Oncol Rep. 2001 Sep;3(5):424-32. doi: 10.1007/s11912-001-0029-0. PMID: 11489244 Review.

Should Radical Nephrectomy Be Performed in the Face of Surgically Incurable Disease?

Yonover PM, Flanigan RC. Curr Opin Urol. 2000 Sep;10(5):429-34. doi: 10.1097/00042307-200009000-00011. PMID: 11005447 Review.

The Role of Radical Nephrectomy in Metastatic Renal Cell Carcinoma

Flanigan RC, Yonover PM. Semin Urol Oncol. 2001 May;19(2):98-102. PMID: 11354539 Review.

Correlation of Radiation Dose and Impotence Risk After Three-Dimensional Conformal Radiotherapy for Prostate Cancer

Mulhall JP, Yonover PM. Urology. 2001 Nov;58(5):828. doi: 10.1016/s0090-4295(01)01415-7. PMID: 11711377 No abstract available.

Mastication Steal: An Unusual Precipitant of Cerebrovascular Insufficiency

Fox D, Herron BE, Yonover PM, Baker WH. J Vasc Surg. 1999 Apr;29(4):734-6. doi: 10.1016/s0741-5214(99)70325-3. PMID: 10194507 Free article.